SCHEMBL19633397

SCHEMBL19633397

CCc1cccc(NC2CCN(S(C)(=O)=O)CC2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP6 P51161 1/20 0.50
NPSR1 Q6W5P4 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
TSHR P16473 2/20 0.49
GAA P10253 1/20 0.49
RORC P51449 1/20 0.48
MAPT P10636 4/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
NSD2 O96028 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
PTPN1 P18031 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
IDO1 P14902 1/20 0.43
CCR6 P51684 1/20 0.43
ROCK2 O75116 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19171044 0.92 MAPT (0.46) FABP6NPSR1MEN1KMT2ATSHR
SCHEMBL17308332 0.92 MAPT (0.46) FABP6NPSR1MEN1KMT2ATSHR
SCHEMBL19171117 0.92 MAPT (0.46) FABP6NPSR1MEN1KMT2ATSHR
SCHEMBL17303771 0.83 TSHR (0.64) FABP6NPSR1MEN1KMT2ATSHR
SCHEMBL15830043 0.82 NPY5R (0.50) FABP6MEN1KMT2ATSHRMAPT
SCHEMBL19957578 0.82 MAPT (0.47) FABP6NPSR1MEN1KMT2ATSHR
SCHEMBL15830434 0.82 KDM4E (0.52) NPSR1MAPTKDM4EALDH1A1NSD2
SCHEMBL17308595 0.81 MEN1 (0.45) FABP6NPSR1MEN1KMT2ATSHR
Hydrochloric Acid SCHEMBL6602265 0.80 SMN1; SMN2 (0.51) NPSR1MEN1KMT2AMAPTKDM4E
SCHEMBL23251072 0.79 KMT2A (0.49) FABP6MEN1KMT2ATSHRRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10307413-B2 Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof Epizyme, Inc. (US) 2019-06-04 US disclosed
US-20170334861-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10307413-B2 Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof PRMT5, PRMT1, PRMT3 FABP6 3641/4885NPSR1 4503/4885MEN1 1665/4885
US-20170334861-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT3 FABP6 3641/4885NPSR1 4503/4885MEN1 1665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.